EUVIMEDEUVIMED entdecken
Crossref

Optimal ImmunoCAP Aspergillus fumigatus ‐Specific IgE Threshold for Detecting Allergic Bronchopulmonary Aspergillosis in Adults With Asthma: A Diagnostic Accuracy Study

Ritesh Agarwal, Puneet Saxena iD, Valliappan Muthu, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Sahajal Dhooria, Mani Singh, Mandeep Garg, Ashutosh N Aggarwal, Shivaprakash M Rudramurthy, Arunaloke Chakrabarti

Clinical & Experimental Allergy · 2026-01 · 56 (1) · 61-67

DOI: 10.1111/cea.70148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 26.09.2025. Verfasst von Ritesh Agarwal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Hauptthemen laut MEDLINE: Aspergillosis, Allergic Bronchopulmonary, Asthma, Aspergillus fumigatus, Immunoglobulin E. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Indian Council of Medical Research, Postgraduate Institute of Medical Education and Research, Chandigarh.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic bronchopulmonary aspergillosis (ABPA) requires screening in adults with asthma using Aspergillus fumigatus ‐specific IgE (Af‐IgE). The current Af‐IgE threshold of 0.35 kUA/L has low specificity, leading to unnecessary downstream testing.

Objectives

To determine an optimal Af‐IgE threshold that maintains high sensitivity while improving specificity for ABPA screening in adults with asthma.

Methods

We performed a diagnostic accuracy study of prospectively collected data using distinct derivation and validation cohorts in a tertiary care setting. The index test was ImmunoCAP Af‐IgE at thresholds of 0.35, 0.70 and 0.90 kUA/L. The reference standard was the 2024 ISHAM‐ABPA criteria applied by investigators aware of all test results.

Results

We included 543 consecutive asthmatic subjects investigated for possible ABPA in the derivation cohort (July 2017–September 2018) and 375 subjects with established asthma and ABPA in the validation dataset (January 2020–December 2023). ABPA prevalence was 19.5% (106/543) in derivation and 69.6% (261/375) in validation cohorts. Bayesian latent class analysis estimated a 0.3 kUA/L cut‐off but did not improve specificity; frequentist analysis showed model misfit. In the validation cohort, increasing the threshold from 0.35 to 0.70 kUA/L improved specificity from 66.7% (95% CI, 57.6–74.7) to 72.8% (95% CI, 64.0–80.1; p = 0.016) without significant sensitivity reduction (100% to 98.9%; 95% CI, 96.7–99.6; p = 0.25). No patients with bronchiectasis were missed. At 0.90 kUA/L, sensitivity significantly decreased (97.7%; 95% CI, 95.1–98.9; p = 0.031).

Conclusions

ImmunoCAP Af‐IgE threshold of 0.70 kUA/L optimised diagnostic performance for ABPA screening in adults with asthma, potentially reducing unnecessary confirmatory testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspergillosis, Allergic BronchopulmonaryAsthmaAspergillus fumigatusImmunoglobulin EAntibodies, FungalHumansMaleFemaleMiddle AgedAdultSensitivity and SpecificityAgedProspective Studies

Stichwörter der Autor:innen

Aspergillusaspergillosisasthmabronchiectasisscreeningsensitivityspecificity

Substanzen

Immunoglobulin EAntibodies, Fungal

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Doodhadhari Burfani Hospital, Haridwar, India.

ORCID-Profile: Puneet Saxena

Förderung

  • Indian Council of Medical Research
  • Postgraduate Institute of Medical Education and Research, Chandigarh

Zitieren

APA

Agarwal, R., Saxena, P., Muthu, V., Sehgal, I. S., Prasad, K. T., Dhooria, S., Singh, M., Garg, M., Aggarwal, A. N., Rudramurthy, S. M., & Chakrabarti, A. (2026). Optimal ImmunoCAP Aspergillus fumigatus ‐Specific IgE Threshold for Detecting Allergic Bronchopulmonary Aspergillosis in Adults With Asthma: A Diagnostic Accuracy Study. Clinical & Experimental Allergy, 56(1), 61-67. https://doi.org/10.1111/cea.70148

Vancouver

Agarwal R, Saxena P, Muthu V, Sehgal IS, Prasad KT, Dhooria S, et al. Optimal ImmunoCAP Aspergillus fumigatus ‐Specific IgE Threshold for Detecting Allergic Bronchopulmonary Aspergillosis in Adults With Asthma: A Diagnostic Accuracy Study. Clinical & Experimental Allergy. 2026;56(1):61-67. doi:10.1111/cea.70148

BibTeX
@article{Agarwal2026,
  author = {Agarwal, Ritesh and Saxena, Puneet and Muthu, Valliappan and Sehgal, Inderpaul Singh and Prasad, Kuruswamy Thurai and Dhooria, Sahajal and Singh, Mani and Garg, Mandeep and Aggarwal, Ashutosh N and Rudramurthy, Shivaprakash M and Chakrabarti, Arunaloke},
  title = {Optimal ImmunoCAP Aspergillus fumigatus ‐Specific IgE Threshold for Detecting Allergic Bronchopulmonary Aspergillosis in Adults With Asthma: A Diagnostic Accuracy Study},
  journal = {Clinical & Experimental Allergy},
  year = {2026},
  volume = {56},
  number = {1},
  pages = {61--67},
  doi = {10.1111/cea.70148}
}
Kostenlos starten →